Our Patient Commitment

As the end-user of our products and services, we are dedicated to improving the quality of life of our patients suffering from a variety of blood clotting disorders, immune deficiencies, and other illnesses.


Learn more 

The Octapharma mission "for the safe and optimal use of human proteins" conveys the company's focus and dedication to a specialized portfolio of products.

 

 

Explore our products 

News & Press Releases

06-18-2018
Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A

Lachen, Switzerland 18 June 2018: Octapharma announced today that the European Medicines Agency...

05-28-2018
Octapharma share promising preclinical data for SubQ-8, a novel subcutaneous recombinant FVIII, at WFH 2018

Lachen, Switzerland 28 May 2018: Octapharma announced today that pre-clinical data for SubQ-8 were p...